Molecular targeted drug |
Immuno-oncology drug | Cytotoxic drug | Others | |
---|---|---|---|---|
TKI | Levantinib | Nivolumab (anti-PD-1) | CBSFlatin (Cisplatin) | JX-594 (virus) |
Refametinib | Tremelimumab | Thermodox (Doxorubicin) | miR-221 (microRNA) | |
(anti-CTLA-4) | ||||
LY2157299 | Livatag (Doxorubicin) | G-202 (peptide) | ||
Regorafenib | WELCOME ANY CHANCE TO COLLABORATION FOR CO-DEVELOPMENT OF DRUG AND CDx |
|||
Tivantinib | ||||
INC280 | ||||
Cabozantinib | ||||
Axitinib | ||||
Erlotinib | ||||
HDACi | Resminostat | |||
Belinostat |
WELCOME ANY CHANCE TO COLLABORATION !!
1 | KCBC : Network of Hepatologists, Surgeons and Physicians in Korea |
2 | Performing biopsy for gene expression analysis in a study trial or routine practice |
3 | Much lower budget for a clinical trial in Korea |
4 | Our experience in regulatory affairs for approval of in vitro diagnostics and investigational new drug with Korea FDA |